S Liu1, U Ajani, C Chae, C Hennekens, J E Buring, J E Manson. 1. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA. simin.liu@channing.harvard.edu
Abstract
CONTEXT: Recent data suggest a protective role of carotenoids in the development of type 2 diabetes mellitus (DM), possibly via an antioxidant effect, but no randomized trial has directly assessed the efficacy of beta-carotene to prevent DM. OBJECTIVE: To determine whether long-term beta-carotene supplementation reduces the risk of developing type 2 DM. DESIGN, SETTING, AND PARTICIPANTS: A total of 22, 071 healthy US male physicians aged 40 to 84 years in a randomized, double- blind, placebo-controlled trial, from 1982 to 1995. More than 99% of the participants had complete follow-up (median duration, 12 years). INTERVENTION: Subjects were randomly assigned to receive beta-carotene (50 mg on alternate days) or placebo. MAIN OUTCOME MEASURE: Incidence of type 2 DM. RESULTS:A total of 10, 756 subjects were assigned to beta-carotene and 10, 712 toplacebo. Incidence of type 2 DM did not differ between groups: 396 men in the beta-carotene group and 402 men in theplacebo group developed type 2 DM (relative risk, 0.98; 95% confidence interval, 0.85-1.12). The lack of association between beta-carotene supplementation and incidence of type 2 DM persisted despite multivariate adjustment. There was no evidence of benefit when the period of risk was subdivided into years of follow-up or increasing duration of treatment. CONCLUSION: In this trial of apparently healthy men, supplementation with beta-carotene for an average of 12 years had no effect on the risk of subsequent type 2 DM.
RCT Entities:
CONTEXT: Recent data suggest a protective role of carotenoids in the development of type 2 diabetes mellitus (DM), possibly via an antioxidant effect, but no randomized trial has directly assessed the efficacy of beta-carotene to prevent DM. OBJECTIVE: To determine whether long-term beta-carotene supplementation reduces the risk of developing type 2 DM. DESIGN, SETTING, AND PARTICIPANTS: A total of 22, 071 healthy US male physicians aged 40 to 84 years in a randomized, double- blind, placebo-controlled trial, from 1982 to 1995. More than 99% of the participants had complete follow-up (median duration, 12 years). INTERVENTION: Subjects were randomly assigned to receive beta-carotene (50 mg on alternate days) or placebo. MAIN OUTCOME MEASURE: Incidence of type 2 DM. RESULTS: A total of 10, 756 subjects were assigned to beta-carotene and 10, 712 to placebo. Incidence of type 2 DM did not differ between groups: 396 men in the beta-carotene group and 402 men in the placebo group developed type 2 DM (relative risk, 0.98; 95% confidence interval, 0.85-1.12). The lack of association between beta-carotene supplementation and incidence of type 2 DM persisted despite multivariate adjustment. There was no evidence of benefit when the period of risk was subdivided into years of follow-up or increasing duration of treatment. CONCLUSION: In this trial of apparently healthy men, supplementation with beta-carotene for an average of 12 years had no effect on the risk of subsequent type 2 DM.
Authors: J R B Perry; L Ferrucci; S Bandinelli; J Guralnik; R D Semba; N Rice; D Melzer; R Saxena; L J Scott; M I McCarthy; A T Hattersley; E Zeggini; M N Weedon; T M Frayling Journal: Diabetologia Date: 2009-08-07 Impact factor: 10.122
Authors: S van Dieren; C S P M Uiterwaal; Y T van der Schouw; D L van der A; J M A Boer; A Spijkerman; D E Grobbee; J W J Beulens Journal: Diabetologia Date: 2009-09-01 Impact factor: 10.122
Authors: May A Beydoun; J Atilio Canas; Hind A Beydoun; Xiaoli Chen; Monal R Shroff; Alan B Zonderman Journal: J Nutr Date: 2012-07-18 Impact factor: 4.798
Authors: M Kataja-Tuomola; J R Sundell; S Männistö; M J Virtanen; J Kontto; D Albanes; J Virtamo Journal: Diabetologia Date: 2007-11-10 Impact factor: 10.122
Authors: J Arnlöv; B Zethelius; U Risérus; S Basu; C Berne; B Vessby; G Alfthan; J Helmersson Journal: Diabetologia Date: 2008-11-05 Impact factor: 10.122
Authors: Yiqing Song; Nancy R Cook; Christine M Albert; Martin Van Denburgh; JoAnn E Manson Journal: Am J Clin Nutr Date: 2009-06-02 Impact factor: 7.045